Shanghai Synvida Biotechnology Co.,ltd.

This study tests a new drug, SV001, in 48 people with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. The main goal is to see if the drug is safe and how the body handles it. Participants will receive either SV001 or a placebo, a…

This early-stage study tests the safety of a new drug called SV003 in 60 healthy volunteers. Participants receive a single dose and are monitored for side effects and how the drug moves through the body. The goal is to gather safety information, not to treat any disease.

This study is an early safety check for a new drug called SV001, which may one day treat idiopathic pulmonary fibrosis (a serious lung disease). It involves 53 healthy adults in China who will receive either a single dose of SV001 or a placebo. The main goal is to see if the drug…